Cargando…

Prevalence of Clinically Relevant Germline BRCA Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience

Breast cancer is a multifaceted disease that currently represents a leading cause of death in women worldwide. Over the past two decades (1998–2020), the National Health Laboratory Service’s Human Genetics Laboratory in central South Africa screened more than 2,974 breast and/or ovarian cancer patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van der Merwe, Nerina C., Combrink, Herkulaas MvE, Ntaita, Kholiwe S., Oosthuizen, Jaco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024354/ https://www.ncbi.nlm.nih.gov/pubmed/35464868 http://dx.doi.org/10.3389/fgene.2022.834265

Ejemplares similares

Implementation of multigene panel testing for breast and ovarian cancer in South Africa: A step towards excellence in oncology for the public sector
por: van der Merwe, Nerina C., et al.
Publicado: (2022)

The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer
por: van der Merwe, Nerina C., et al.
Publicado: (2020)

Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study
por: Oosthuizen, Jaco, et al.
Publicado: (2021)

Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer
por: Nicolussi, Arianna, et al.
Publicado: (2019)

Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan
por: Muhammad, Noor, et al.
Publicado: (2023)

BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families
por: Claes, K, et al.
Publicado: (2004)

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
por: Kalachand, Roshni D., et al.
Publicado: (2020)

Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer
por: Chen, Bo, et al.
Publicado: (2020)

Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia
por: Wen, Wei Xiong, et al.
Publicado: (2018)

COVID-19 in South Africa
por: Broadbent, Alex, et al.
Publicado: (2020)

Corrigendum to “COVID-19 in South Africa” [Global Epidemiology 2 (2020) 100034]
por: Broadbent, Alex, et al.
Publicado: (2021)

Reply to Lurie et al.
por: Broadbent, Alex, et al.
Publicado: (2021)

A South African Indian population group dataset for breast cancer and BRCA1/2 variants
por: Combrink, H.M.V.E., et al.
Publicado: (2022)

The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2
por: Philpott, Sue, et al.
Publicado: (2023)

Germline BRCA1 mutations increase prostate cancer risk
por: Leongamornlert, D, et al.
Publicado: (2012)

Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer
por: Hirasawa, Akira, et al.
Publicado: (2017)

Germline Copy Number Variation and Ovarian Cancer Survival
por: Fridley, Brooke L., et al.
Publicado: (2012)

The frequency of somatic mutations in cancer predicts the phenotypic relevance of germline mutations
por: Draetta, Edoardo Luigi, et al.
Publicado: (2023)

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
por: Edwards, S M, et al.
Publicado: (2010)

BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer
por: Nilsson, Martin P., et al.
Publicado: (2017)

Germline pathogenic variants in unselected Korean men with prostate cancer
por: So, Min-Kyung, et al.
Publicado: (2022)

A comparative study of germline BRCA1 and BRCA2 mutation screening methods in use in 20 European clinical diagnostic laboratories
por: Ellison, Gillian, et al.
Publicado: (2017)

A Pathogenic Germline BRCA1 Variant in a Patient With Cellular Congenital Mesoblastic Nephroma: A Case Report
por: Dholakia, Gayatri, et al.
Publicado: (2023)

Germline truncating mutations in both MSH2 and BRCA2 in a single kindred
por: Thiffault, I, et al.
Publicado: (2004)

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer
por: Agalliu, I, et al.
Publicado: (2007)

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece
por: Koumpis, Chrissovaladis, et al.
Publicado: (2011)

Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil
por: Maistro, Simone, et al.
Publicado: (2016)

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
por: Ferreyra, Yomali, et al.
Publicado: (2023)

Germline BRCA1 Mutation Detected in a Multiple Endocrine Neoplasia Type 2 Case With RET Codon 634 Mutation
por: Sarkadi, Balázs, et al.
Publicado: (2019)

A Novel Germline Compound Heterozygous Mutation of BRCA2 Gene Associated With Familial Peripheral Neuroblastic Tumors in Two Siblings
por: Yang, Yeran, et al.
Publicado: (2021)

BRCA1/2 mutations, including large genomic rearrangements, among unselected ovarian cancer patients in Korea
por: Kim, Do-Hoon, et al.
Publicado: (2018)

Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation
por: Pujol, Pascal, et al.
Publicado: (2022)

Ovarian Cancer With Breast Metastasis and Two Pathogenic Variants of BRCA1 Gene
por: Kowsarnia, Saeedeh, et al.
Publicado: (2021)

Senataxin: A New Guardian of the Female Germline Important for Delaying Ovarian Aging
por: Homer, Hayden A.
Publicado: (2021)

BRCA germline mutation test for all woman with ovarian cancer?
por: Paradiso, A. V., et al.
Publicado: (2019)

Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients
por: Yang, Jie, et al.
Publicado: (2021)

The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients
por: Chen-Shtoyerman, R, et al.
Publicado: (2001)

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia
por: Hernández, Julián Esteban Londoño, et al.
Publicado: (2014)

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
por: Li, Jingmei, et al.
Publicado: (2018)

Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
por: Ligtenberg, M J L, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_a3l0rkg6u22uq1j95epnjf7a8p